580 related articles for article (PubMed ID: 17952066)
41. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
[TBL] [Abstract][Full Text] [Related]
42. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.
Parish CR; Freeman C; Brown KJ; Francis DJ; Cowden WB
Cancer Res; 1999 Jul; 59(14):3433-41. PubMed ID: 10416607
[TBL] [Abstract][Full Text] [Related]
43. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
44. Heparanase: Historical Aspects and Future Perspectives.
Khanna M; Parish CR
Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
[TBL] [Abstract][Full Text] [Related]
45. Heparin, heparan sulfate and heparanase in inflammatory reactions.
Li JP; Vlodavsky I
Thromb Haemost; 2009 Nov; 102(5):823-8. PubMed ID: 19888515
[TBL] [Abstract][Full Text] [Related]
46. Heparanase in glomerular diseases.
van den Hoven MJ; Rops AL; Vlodavsky I; Levidiotis V; Berden JH; van der Vlag J
Kidney Int; 2007 Sep; 72(5):543-8. PubMed ID: 17519955
[TBL] [Abstract][Full Text] [Related]
47. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
[TBL] [Abstract][Full Text] [Related]
48. Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.
Goodall KJ; Poon IK; Phipps S; Hulett MD
PLoS One; 2014; 9(10):e109596. PubMed ID: 25295599
[TBL] [Abstract][Full Text] [Related]
49. Heparan sulfate proteoglycans in beta cells provide a critical link between endoplasmic reticulum stress, oxidative stress and type 2 diabetes.
Dhounchak S; Popp SK; Brown DJ; Laybutt DR; Biden TJ; Bornstein SR; Parish CR; Simeonovic CJ
PLoS One; 2021; 16(6):e0252607. PubMed ID: 34086738
[TBL] [Abstract][Full Text] [Related]
50. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
51. Tinkering with heparan sulfate sulfation to steer development.
Gorsi B; Stringer SE
Trends Cell Biol; 2007 Apr; 17(4):173-7. PubMed ID: 17320398
[TBL] [Abstract][Full Text] [Related]
52. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.
Levy-Adam F; Abboud-Jarrous G; Guerrini M; Beccati D; Vlodavsky I; Ilan N
J Biol Chem; 2005 May; 280(21):20457-66. PubMed ID: 15760902
[TBL] [Abstract][Full Text] [Related]
53. Heparanase involvement in physiology and disease.
Nasser NJ
Cell Mol Life Sci; 2008 Jun; 65(11):1706-15. PubMed ID: 18425416
[TBL] [Abstract][Full Text] [Related]
54. Heparan sulfate-protein interactions--a concept for drug design?
Lindahl U
Thromb Haemost; 2007 Jul; 98(1):109-15. PubMed ID: 17598000
[TBL] [Abstract][Full Text] [Related]
55. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
[TBL] [Abstract][Full Text] [Related]
56. The impact of heparanese and heparin on cancer metastasis and angiogenesis.
Vlodavsky I; Abboud-Jarrous G; Elkin M; Naggi A; Casu B; Sasisekharan R; Ilan N
Pathophysiol Haemost Thromb; 2006; 35(1-2):116-27. PubMed ID: 16855356
[TBL] [Abstract][Full Text] [Related]
57. Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy.
Bode L; Eklund EA; Murch S; Freeze HH
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1015-23. PubMed ID: 15604198
[TBL] [Abstract][Full Text] [Related]
58. Mapping critical biological motifs and biosynthetic pathways of heparan sulfate.
Lawrence R; Kuberan B; Lech M; Beeler DL; Rosenberg RD
Glycobiology; 2004 May; 14(5):467-79. PubMed ID: 15033939
[TBL] [Abstract][Full Text] [Related]
59. Heparanase expression and function during early pregnancy in mice.
D'Souza SS; Daikoku T; Farach-Carson MC; Carson DD
Biol Reprod; 2007 Sep; 77(3):433-41. PubMed ID: 17507691
[TBL] [Abstract][Full Text] [Related]
60. Heparanase multiple effects in cancer.
Nadir Y; Brenner B
Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
